Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
World J Surg ; 47(2): 330-339, 2023 02.
Article in English | MEDLINE | ID: mdl-36336771

ABSTRACT

BACKGROUND: Current diagnosis and classification of thyroid nodules are susceptible to subjective factors. Despite widespread use of ultrasonography (USG) and fine needle aspiration cytology (FNAC) to assess thyroid nodules, the interpretation of results is nuanced and requires specialist endocrine surgery input. Using readily available pre-operative data, the aims of this study were to develop artificial intelligence (AI) models to classify nodules into likely benign or malignant and to compare the diagnostic performance of the models. METHODS: Patients undergoing surgery for thyroid nodules between 2010 and 2020 were recruited from our institution's database into training and testing groups. Demographics, serum TSH level, cytology, ultrasonography features and histopathology data were extracted. The training group USG images were re-reviewed by a study radiologist experienced in thyroid USG, who reported the relevant features and supplemented with data extracted from existing reports to reduce sampling bias. Testing group USG features were extracted solely from existing reports to reflect real-life practice of a non-thyroid specialist. We developed four AI models based on classification algorithms (k-Nearest Neighbour, Support Vector Machine, Decision Tree, Naïve Bayes) and evaluated their diagnostic performance of thyroid malignancy. RESULTS: In the training group (n = 857), 75% were female and 27% of cases were malignant. The testing group (n = 198) consisted of 77% females and 17% malignant cases. Mean age was 54.7 ± 16.2 years for the training group and 50.1 ± 17.4 years for the testing group. Following validation with the testing group, support vector machine classifier was found to perform best in predicting final histopathology with an accuracy of 89%, sensitivity 89%, specificity 83%, F-score 94% and AUROC 0.86. CONCLUSION: We have developed a first of its kind, pilot AI model that can accurately predict malignancy in thyroid nodules using USG features, FNAC, demographics and serum TSH. There is potential for a model like this to be used as a decision support tool in under-resourced areas as well as by non-thyroid specialists.


Subject(s)
Thyroid Neoplasms , Thyroid Nodule , Female , Humans , Adult , Middle Aged , Aged , Male , Thyroid Nodule/diagnostic imaging , Thyroid Nodule/surgery , Artificial Intelligence , Bayes Theorem , Predictive Value of Tests , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/surgery , Ultrasonography , Thyrotropin , Sensitivity and Specificity
3.
PLoS One ; 11(1): e0147247, 2016.
Article in English | MEDLINE | ID: mdl-26799066

ABSTRACT

Despite extensive control efforts, schistosomiasis continues to be a major public health problem in developing nations in the tropics and sub-tropics. The miracidium, along with the cercaria, both of which are water-borne and free-living, are the only two stages in the life-cycle of Schistosoma mansoni which are involved in host invasion. Miracidia penetrate intermediate host snails and develop into sporocysts, which lead to cercariae that can infect humans. Infection of the snail host by the miracidium represents an ideal point at which to interrupt the parasite's life-cycle. This research focuses on an analysis of the miracidium proteome, including those proteins that are secreted. We have identified a repertoire of proteins in the S. mansoni miracidium at 2 hours post-hatch, including proteases, venom allergen-like proteins, receptors and HSP70, which might play roles in snail-parasite interplay. Proteins involved in energy production and conservation were prevalent, as were proteins predicted to be associated with defence. This study also provides a strong foundation for further understanding the roles that neurohormones play in host-seeking by schistosomes, with the potential for development of novel anthelmintics that interfere with its various life-cycle stages.


Subject(s)
Biomphalaria/immunology , Cercaria/genetics , Protozoan Proteins/immunology , Schistosoma mansoni/immunology , Schistosomiasis/immunology , Animals , Biomphalaria/parasitology , Cercaria/growth & development , Disease Vectors , Energy Metabolism/genetics , Gene Expression Profiling , Genome, Protozoan/genetics , Host-Parasite Interactions/genetics , Host-Parasite Interactions/immunology , Life Cycle Stages , Mice , Neuropeptides/genetics , Oocysts/growth & development , Proteome/genetics , Proteomics , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Schistosoma mansoni/genetics , Schistosomiasis/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...